Companies /Technology

Microchip Technology Inc

NASDAQ: MCHP Semiconductors
$75.49
â–² $1.44 (+1.94%) today
Markets closed · 7:26am ET

Q4 2025 Earnings

Reported May 8, 2025, 4:17pm ET · SEC source
$0.11
Beat +5.26%
EPS · est. $0.10
$970.5M
Beat +1.01%
Revenue · est. $960.8M
+19.2%
Beating market
MCHP vs S&P since report
6 quarters
Consecutive EPS beats

Market Reaction

% change · around the report
−4%0+4%+8%May 8May 9report 4:17pm ETearnings+0.0%+8.6%
−4%0+4%+8%May 8May 9earnings+0.0%+8.6%
MCHP +8.6%S&P 500 +0.0%
−4%0+4%+8%May 8May 9report 4:17pm ETearnings−0.1%+8.2%
−4%0+4%+8%May 8May 9earnings−0.1%+8.2%
MCHP +8.2%NASDAQ −0.1%
−9%0+9%+18%May 7May 16report 4:17pm ETearnings+4.8%+17.9%
−9%0+9%+18%May 7May 16earnings+4.8%+17.9%
MCHP +17.9%S&P 500 +4.8%
−9%0+9%+18%May 7May 16report 4:17pm ETearnings+6.3%+17.9%
−9%0+9%+18%May 7May 16earnings+6.3%+17.9%
MCHP +17.9%NASDAQ +6.3%
+12.60%
Day of report
+10.18%
Next session
+10.63%
One week
+25.79%
30 days

S&P 500 over the same 30 days: +6.56%.

Did MCHP Beat Earnings? Q4 2025 Results

Microchip Technology posted a better-than-expected fiscal fourth quarter, with revenue of $970.50 million edging past the $951.29 million consensus by 2.02% and non-GAAP EPS of $0.11 beating the $0.10 estimate by 10%, even as both metrics reflected the ongoing severity of an industry downcycle that pushed net sales down 26.8% year over year. The clearest signal of a potential inflection came from the demand side, where the company recorded its first positive book-to-bill ratio in nearly three years, with April bookings exceeding any month in the March quarter, giving management confidence that the period marks a cyclical trough. Inventory reduction also stood out, with overall inventory dollars falling $62.80 million and balance sheet inventory days declining by 15 days sequentially. On the balance sheet, a mandatory convertible preferred offering helped reduce total net debt by roughly $1.30 billion during the quarter. Looking ahead, Microchip guided Q1 fiscal 2026 revenue of $1.02 billion to $1.07 billion, a return to sequential growth, though analysts remain divided on whether the valuation fully reflects the risks that still linger, including tariff uncertainty and a prolonged recovery timeline.

Key Takeaways
  • Nine-point plan driving operational efficiency improvements in manufacturing and inventory management
  • Inventory reduction strategy — overall inventory dollars down $62.8 million, distribution inventory days reduced by 4 days to 33 days
  • First positive book-to-bill ratio in nearly three years
  • April bookings higher than any month in the March quarter
  • Net debt reduction of approximately $1.3 billion through mandatory convertible preferred offering

“Our March quarter revenue of $970.5 million exceeded the midpoint of our guidance, and we believe marks the bottom of this prolonged industry down cycle for Microchip. The decisive actions we have taken under our nine-point-plan are enhancing our operational capabilities through more efficient manufacturing, improving inventory management, and a renewed strategic focus. As we move forward from a challenging fiscal year, we believe Microchip is better positioned to capitalize on growth opportunities as market conditions evolve.”

Microchip Technology CEO, on the earnings call

Forward Guidance & Outlook

For Q1 fiscal 2026 (quarter ending June 30, 2025), Microchip guides net sales of $1.020 billion to $1.070 billion, representing a return to sequential growth. Non-GAAP gross profit margin is expected at 52.2% to 54.2%, with non-GAAP operating income margin of 17.4% to 20.8%. Non-GAAP EPS is guided at $0.18 to $0.26. GAAP diluted loss per share is expected between ($0.15) and ($0.07). Capital expenditures for Q1 FY2026 are expected between $20 million and $25 million, and at or below $100 million for all of fiscal 2026. Management noted the first positive book-to-bill ratio in nearly three years, with April bookings exceeding any month in the March quarter, though geopolitical concerns and tariff impacts remain non-quantifiable risks.

MCHP YoY Financials

Q4 2025 vs Q4 2024 · SEC filings Q4 2024 Q4 2025
$0$400.0M$800.0M$1.2B$1.3B$970.5MRevenue$789.9M$501.1MGross Profit
$0$400.0M$800.0M$1.2BRevenueGross Profit

Figures from SEC filings and company reports. Not investment advice.